Cincinnati Business Courier: Flash therapy for cancer
Clinical trial led by a UC faculty member looks at cancer therapy delivered in less than a second
UC researchers treated their first study patient this week using a new cancer therapy that takes less than one second.
The trial, being hosted at the Cincinnati Children's Hospital Medical Center/UC Health Proton Therapy Center, is looking at what is known as "flash" therapy, a new mode of radiation that can be delivered to a patient in as little as a single session that lasts less than one second. It is up to 100 times faster than traditional radiation therapy, which delivers the same dose over minutes.
The study patient, the first in the world to participate in the clinical trial, was treated this week at the center. Up to 10 patients, whose metastatic cancer has spread to their bones, will participate in the research clinical trial.
John Breneman, MD, a professor emeritus at UC who is medical director of the center, a UC Health radiation oncologist and principal investigator on the study, says the patient's treatment went very well.
“The prior three years of preparation by the researchers, engineers, clinical and physics teams culminated in a treatment that was completed in literally a blink of the eye, and the patient was discharged,” he says.
Read the full Cincinnati Business Courier story. This publication may require a login.
Read coverage at Healthcare Business News.
Read the Cincinnati Children's media release.
Featured photo of the Cincinnati Children's/UC Health Proton Therapy Center taken in 2019 by Colleen Kelley/UC Creative + Brand.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up on all UC's COVID-19 stories, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.